Bilanafos

TargetMol
Product Code: TAR-T20159
Supplier: TargetMol
CodeSizePrice
TAR-T20159-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T20159-50mg50mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T20159-5mg5mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Bilanafos is an agent of Anti-Bacterial.
CAS:
35597-43-4
Formula:
C11H22N3O6P
Molecular Weight:
323.286
Purity:
0.98
SMILES:
C[C@H](NC(=O)[C@H](C)NC(=O)C(N)CCP(=O)CO)C(O)=O

References

1. Bilanakis N, Vratsista A, Siorou S. A brain ependymoma with psychiatric manifestation. J BUON. 2017 Nov-Dec;22(6):1604-1605. PubMed PMID: 29332363. 2. Bilanakis N, Peritogiannis VK, Vratsista A. Treatment decision-making capacity in hospitalized patients with schizophrenia. Psychiatriki. 2017 Jan-Mar;28(1):37-45. doi: 10.22365/jpsych.2017.281.37. PubMed PMID: 28541237. 3. Hargarter L, Bergmans P, Cherubin P, Keim S, Conca A, Serrano-Blanco A, Bitter I, Bilanakis N, Schreiner A. Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia. Expert Opin Pharmacother. 2016 Jun;17(8):1043-53. doi: 10.1080/14656566.2016.1174692. Epub 2016 May 9. PubMed PMID: 27042990; PubMed Central PMCID: PMC4898156. 4. Bilanakis N, Vratsista A, Athanasiou E, Niakas D, Peritogiannis V. Medical patients' treatment decision making capacity: a report from a general hospital in Greece. Clin Pract Epidemiol Ment Health. 2014 Nov 26;10:133-9. doi: 10.2174/1745017901410010133. eCollection 2014. PubMed PMID: 25505489; PubMed Central PMCID: PMC4260233.